Transplant experts are seeing a spike in people revoking organ donor registrations, their confidence shaken by reports that organs were nearly retrieved from a Kentucky man mistakenly declared dead. It happened in 2021 and while details are murky surgery was avoided and the man is still alive. But donor registries in the U.S. and even across the Atlantic are being impacted after the case was publicized recently. A drop in donations could cost the lives of people awaiting a transplant.
HCA Healthcare says hurricanes Helene and Milton will cause $250 million to $350 million in additional expenses and lost revenue at its facilities in Florida and other states. In a report filed with the SEC, the hospital industry giant says that during Q3, it incurred an estimated $50 million in additional expenses and lost revenue in Florida, Georgia and North Carolina because of Helene. It expects additional expenses during the fourth quarter of $200 million to $300 million because of continued effects of Helene in North Carolina and because of Milton.
Federal regulators are confronting a new twist in drug development: manufacturers that include software with the medicine to prod patients to take pills as directed, manage side effects or track how well a treatment works. The apps could boost the drugs' clinical value and provide a more personalized approach to managing chronic conditions such as depression, obesity and musculoskeletal problems.
A month after Atrium announced it was erasing thousands of judgments filed against patients for medical debt, four other N.C. hospitals with large numbers of medical debt lawsuits said they have taken the same step.
Envision Healthcare announced the appointment of J. Michael Bruff as CFO. Bruff steps into the role as current Envision CFO Henry Howe prepares to transition out of the organization at the beginning of January. Howe will serve as a senior advisor to the executive team during the transition. Megan Barney, Envision's current CIO, also will be departing in early January. The organization has started a search to fill the position.
More than a year has passed since Dana-Farber Cancer Institute dumped Mass General Brigham for a rival hospital chain, but the state's biggest healthcare system is making a push now to say when it comes to cancer care, MGB's still got it. Dana-Farber's announcement of the divorce in September 2023 stunned executives at the Brigham and rocked the hyper-competitive hospital industry. But now MGB is fighting back by creating what it calls the Mass General Brigham Cancer Institute, which the health system is trumpeting in an intensive marketing campaign.